{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:34:38Z","timestamp":1787020478662,"version":"build-2736575974"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"GlaxoSmithKline AG"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"DOI":"10.1186\/s12931-025-03352-0","type":"journal-article","created":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T10:47:48Z","timestamp":1758883668000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Acute COPD exacerbation despite triple inhaled therapy: a molecular insight \u2013 TripleEx study"],"prefix":"10.1186","volume":"26","author":[{"given":"Noriane A.","family":"Sievi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Fricke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego M.","family":"Baur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Basler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Herth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malcolm","family":"Kohler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,26]]},"reference":[{"issue":"5","key":"3352_CR1","doi-asserted-by":"publisher","first-page":"375","DOI":"10.3109\/15412555.2010.510160","volume":"7","author":"CE Berry","year":"2010","unstructured":"Berry CE, Wise RA. Mortality in COPD: causes, risk factors, and prevention. COPD: Journal of Chronic Obstructive Pulmonary Disease. 2010;7(5):375\u201382.","journal-title":"COPD: Journal of Chronic Obstructive Pulmonary Disease"},{"issue":"2","key":"3352_CR2","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s10096-002-0872-4","volume":"22","author":"D Lieberman","year":"2003","unstructured":"Lieberman D, Shmarkov O, Gelfer Y, et al. Prevalence and clinical significance of fever in acute exacerbations of chronic obstructive pulmonary disease. Eur J Clin Microbiol Infect Dis. 2003;22(2):75\u20138.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"4","key":"3352_CR3","first-page":"354","volume":"61","author":"DE O\u2019Donnell","year":"2006","unstructured":"O\u2019Donnell DE, Parker CM. COPD exacerbations. 3: Pathophysiology Thorax. 2006;61(4):354\u201361.","journal-title":"3: Pathophysiology Thorax"},{"issue":"5","key":"3352_CR4","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1136\/thx.2003.008730","volume":"59","author":"M Miravitlles","year":"2004","unstructured":"Miravitlles M, Ferrer M, Pont A, et al. Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow up study. Thorax. 2004;59(5):387\u201395.","journal-title":"Thorax"},{"issue":"116","key":"3352_CR5","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1183\/09059180.00002610","volume":"19","author":"A Anzueto","year":"2010","unstructured":"Anzueto A. Impact of exacerbations on COPD. Eur Respir Rev. 2010;19(116):113\u20138.","journal-title":"Eur Respir Rev"},{"issue":"7","key":"3352_CR6","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1111\/crj.13026","volume":"13","author":"Y Zayed","year":"2019","unstructured":"Zayed Y, Barbarawi M, Kheiri B, et al. Triple versus dual inhaler therapy in moderate-to-severe COPD: a systematic review and meta-analysis of randomized controlled trials. Clin Respir J. 2019;13(7):413\u201328.","journal-title":"Clin Respir J"},{"key":"3352_CR7","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.2147\/COPD.S163717","volume":"13","author":"S Chen","year":"2018","unstructured":"Chen S, Small M, Lindner L, Xu X. Symptomatic burden of COPD for patients receiving dual or triple therapy. Int J Chron Obstruct Pulmon Dis. 2018;13:1365\u201376.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"3352_CR8","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.aca.2018.01.069","volume":"1024","author":"MAG Wallace","year":"2018","unstructured":"Wallace MAG, Pleil JD. Evolution of clinical and environmental health applications of exhaled breath research: review of methods and instrumentation for gas-phase, condensate, and aerosols. Anal Chim Acta. 2018;1024:18\u201338.","journal-title":"Anal Chim Acta"},{"issue":"2","key":"3352_CR9","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.chest.2018.12.023","volume":"156","author":"MT Gaugg","year":"2019","unstructured":"Gaugg MT, Nussbaumer-Ochsner Y, Bregy L, et al. Real-time breath analysis reveals specific metabolic signatures of COPD exacerbations. Chest. 2019;156(2):269\u201376.","journal-title":"Chest"},{"key":"3352_CR10","doi-asserted-by":"publisher","DOI":"10.1088\/1752-7163\/ad9ac4","author":"S Basler","year":"2024","unstructured":"Basler S, Sievi NA, Schmidt F, et al. Molecular breath profile of acute COPD exacerbations. J Breath Res. 2024. https:\/\/doi.org\/10.1088\/1752-7163\/ad9ac4.","journal-title":"J Breath Res"},{"issue":"12","key":"3352_CR11","doi-asserted-by":"publisher","first-page":"105557","DOI":"10.1016\/j.isci.2022.105557","volume":"25","author":"A Gisler","year":"2022","unstructured":"Gisler A, Singh KD, Zeng J, et al. An interoperability framework for multicentric breath metabolomic studies. iScience. 2022;25(12):105557.","journal-title":"iScience"},{"issue":"19","key":"3352_CR12","doi-asserted-by":"publisher","first-page":"4883","DOI":"10.1007\/s00216-019-01764-8","volume":"411","author":"KD Singh","year":"2019","unstructured":"Singh KD, Tancev G, Decrue F, et al. Standardization procedures for real-time breath analysis by secondary electrospray ionization high-resolution mass spectrometry. Anal Bioanal Chem. 2019;411(19):4883\u201398.","journal-title":"Anal Bioanal Chem"},{"issue":"3","key":"3352_CR13","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1111\/1467-9868.00346","volume":"64","author":"JD Storey","year":"2002","unstructured":"Storey JD. A direct approach to false discovery rates. J R Stat Soc Series B Stat Methodol. 2002;64(3):479\u201398.","journal-title":"J R Stat Soc Series B Stat Methodol"},{"key":"3352_CR14","doi-asserted-by":"crossref","unstructured":"Kononenko I, editor. editor The minimum description length based decision tree pruning. Berlin, Heidelberg: Springer; 1998.","DOI":"10.1007\/BFb0095272"},{"issue":"W1","key":"3352_CR15","doi-asserted-by":"publisher","first-page":"W388","DOI":"10.1093\/nar\/gkab382","volume":"49","author":"Z Pang","year":"2021","unstructured":"Pang Z, Chong J, Zhou G, et al. MetaboAnalyst 5.0: narrowing the gap between Raw spectra and functional insights. Nucleic Acids Res. 2021;49(W1):W388\u201396.","journal-title":"Nucleic Acids Res"},{"key":"3352_CR16","unstructured":"The Metabolomics Workbench. RefMet: A Reference list of Metabolite names Available from: https:\/\/www.metabolomicsworkbench.org\/databases\/refmet\/index.php. Accessed 03.04.2025."},{"key":"3352_CR17","doi-asserted-by":"publisher","DOI":"10.1088\/1752-7163\/abf1d0","author":"N Drabi\u0144ska","year":"2021","unstructured":"Drabi\u0144ska N, Flynn C, Ratcliffe N, et al. A literature survey of all volatiles from healthy human breath and bodily fluids: the human volatilome. J Breath Res. 2021. https:\/\/doi.org\/10.1088\/1752-7163\/abf1d0.","journal-title":"J Breath Res"},{"issue":"4","key":"3352_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.bj.2023.100623","volume":"46","author":"PC Moura","year":"2023","unstructured":"Moura PC, Raposo M, Vassilenko V. Breath volatile organic compounds (VOCs) as biomarkers for the diagnosis of pathological conditions: a review. Biomed J. 2023;46(4):100623.","journal-title":"Biomed J"},{"issue":"4","key":"3352_CR19","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1021\/es5002105","volume":"48","author":"EL Schymanski","year":"2014","unstructured":"Schymanski EL, Jeon J, Gulde R, et al. Identifying small molecules via high resolution mass spectrometry: communicating confidence. Environ Sci Technol. 2014;48(4):2097\u20138.","journal-title":"Environ Sci Technol"},{"issue":"5","key":"3352_CR20","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1513\/pats.200601-006AW","volume":"3","author":"DS Postma","year":"2006","unstructured":"Postma DS, Timens W. Remodeling in asthma and chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2006;3(5):434\u20139.","journal-title":"Proc Am Thorac Soc"},{"key":"3352_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23126400","author":"R Caird","year":"2022","unstructured":"Caird R, Williamson M, Yusuf A, et al. Targeting of glycosaminoglycans in genetic and inflammatory airway disease. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms23126400.","journal-title":"Int J Mol Sci"},{"key":"3352_CR22","doi-asserted-by":"crossref","unstructured":"Papakonstantinou E, Bonovolias I, Roth M et al. Serum levels of hyaluronic acid are associated with COPD severity and predict survival. Eur Respir J. 2019;53(3):1801183.","DOI":"10.1183\/13993003.01183-2018"},{"issue":"6","key":"3352_CR23","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1378\/chest.15-0153","volume":"148","author":"E Papakonstantinou","year":"2015","unstructured":"Papakonstantinou E, Roth M, Klagas I, et al. COPD exacerbations are associated with proinflammatory degradation of hyaluronic acid. Chest. 2015;148(6):1497\u2013507.","journal-title":"Chest"},{"key":"3352_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/biom12050658","author":"A Hoarau","year":"2022","unstructured":"Hoarau A, Polette M, Coraux C. Lung hyaluronasome: involvement of low molecular weight Ha (Lmw-Ha) in innate immunity. Biomolecules. 2022. https:\/\/doi.org\/10.3390\/biom12050658.","journal-title":"Biomolecules"},{"issue":"7","key":"3352_CR25","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1111\/j.1476-5381.2009.00279.x","volume":"157","author":"E Papakonstantinou","year":"2009","unstructured":"Papakonstantinou E, Karakiulakis G. The \u2018sweet\u2019 and \u2018bitter\u2019 involvement of glycosaminoglycans in lung diseases: pharmacotherapeutic relevance. Br J Pharmacol. 2009;157(7):1111\u201327.","journal-title":"Br J Pharmacol"},{"issue":"3","key":"3352_CR26","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1183\/09031936.00070808","volume":"34","author":"I Klagas","year":"2009","unstructured":"Klagas I, Goulet S, Karakiulakis G, et al. Decreased hyaluronan in airway smooth muscle cells from patients with asthma and COPD. Eur Respir J. 2009;34(3):616\u201328.","journal-title":"Eur Respir J"},{"issue":"2","key":"3352_CR27","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cbpb.2007.10.009","volume":"149","author":"B Moussian","year":"2008","unstructured":"Moussian B. The role of GlcNAc in formation and function of extracellular matrices. Comp Biochem Physiol B Biochem Mol Biol. 2008;149(2):215\u201326.","journal-title":"Comp Biochem Physiol B Biochem Mol Biol"},{"key":"3352_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.596617","volume":"12","author":"A Qiang","year":"2021","unstructured":"Qiang A, Slawson C, Fields PE. The role of O-GlcNAcylation in immune cell activation. Front Endocrinol (Lausanne). 2021;12:596617.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"3352_CR29","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.02374-20","author":"M Chatterjee","year":"2020","unstructured":"Chatterjee M, van Putten JPM, Strijbis K. Defensive properties of mucin glycoproteins during respiratory infections-relevance for SARS-CoV-2. mBio. 2020. https:\/\/doi.org\/10.1128\/mBio.02374-20.","journal-title":"mBio"},{"key":"3352_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/genes14040933","author":"A Paneque","year":"2023","unstructured":"Paneque A, Fortus H, Zheng J, et al. The hexosamine biosynthesis pathway: regulation and function. Genes (Basel). 2023. https:\/\/doi.org\/10.3390\/genes14040933.","journal-title":"Genes (Basel)"},{"key":"3352_CR31","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.pupt.2017.08.007","volume":"48","author":"E Papakonstantinou","year":"2018","unstructured":"Papakonstantinou E, Klagas I, Karakiulakis G, et al. Glucocorticoids and beta(2)-agonists regulate the pathologic metabolism of hyaluronic acid in COPD. Pulm Pharmacol Ther. 2018;48:104\u201310.","journal-title":"Pulm Pharmacol Ther"},{"key":"3352_CR32","doi-asserted-by":"publisher","first-page":"101","DOI":"10.2174\/1874306401408010101","volume":"8","author":"F Egbuonu","year":"2014","unstructured":"Egbuonu F, Antonio FA, Edavalath M. Effect of inhaled corticosteroids on glycemic status. Open Respir Med J. 2014;8:101\u20135.","journal-title":"Open Respir Med J"},{"key":"3352_CR33","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.plipres.2017.09.004","volume":"68","author":"JM Galano","year":"2017","unstructured":"Galano JM, Lee YY, Oger C, et al. Isoprostanes, neuroprostanes and phytoprostanes: an overview of 25years of research in chemistry and biology. Prog Lipid Res. 2017;68:83\u2013108.","journal-title":"Prog Lipid Res"},{"issue":"3","key":"3352_CR34","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.bbalip.2018.11.012","volume":"1864","author":"AM van der Does","year":"2019","unstructured":"van der Does AM, Heijink M, Mayboroda OA, et al. Dynamic differences in dietary polyunsaturated fatty acid metabolism in sputum of COPD patients and controls. Biochimica et Biophysica Acta (BBA). 2019;1864(3):224\u201333.","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"key":"3352_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23094768","author":"S Kotlyarov","year":"2022","unstructured":"Kotlyarov S. Role of short-chain fatty acids produced by gut microbiota in innate lung immunity and pathogenesis of the heterogeneous course of chronic obstructive pulmonary disease. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms23094768.","journal-title":"Int J Mol Sci"},{"key":"3352_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2022.1011732","volume":"9","author":"RO Correa","year":"2022","unstructured":"Correa RO, Castro PR, Moser R, et al. Butyrate: connecting the gut-lung axis to the management of pulmonary disorders. Front Nutr. 2022;9:1011732.","journal-title":"Front Nutr"},{"issue":"1","key":"3352_CR37","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1186\/s12931-021-01872-z","volume":"22","author":"N Li","year":"2021","unstructured":"Li N, Dai Z, Wang Z, et al. Gut microbiota dysbiosis contributes to the development of chronic obstructive pulmonary disease. Respir Res. 2021;22(1):274.","journal-title":"Respir Res"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-025-03352-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-025-03352-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-025-03352-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T10:47:50Z","timestamp":1758883670000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-025-03352-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,26]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3352"],"URL":"https:\/\/doi.org\/10.1186\/s12931-025-03352-0","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,26]]},"assertion":[{"value":"16 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the cantonal ethics committee of Zurich (BASEC-Nr. 2020\u2009\u2212\u200901954) and all participants provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"273"}}